NeuroOne® to Participate in the 36th Annual Roth Conference
March 08 2024 - 12:00PM
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)
("NeuroOne" or the "Company"), a medical technology company focused
on improving surgical care options and outcomes for patients
suffering from neurological disorders, today announced its
participation in the 36th Annual Roth Conference being
held March 17-19, 2024 in Dana Point, California. Chief
Executive Offer Dave Rosa and Chief Financial Officer Ron McClurg
will host one-on-one meetings with institutional investors and
analysts on Monday, March 18th and Tuesday, March 19th.
Conference Details:
Location: |
The Ritz Carlton, Laguna Niguel in Dana Point,
California. |
Registration: |
Available on the conference website. |
1x1 meetings: |
Investors may request a meeting by contacting a Roth representative
at 800.678.9147 or by contacting NeuroOne investor
relations. |
About NeuroOne
NeuroOne Medical Technologies Corporation is a
developmental stage company committed to providing minimally
invasive and hi-definition solutions for EEG recording, brain
stimulation and ablation solutions for patients suffering from
epilepsy, Parkinson's disease, dystonia, essential tremors, chronic
pain due to failed back surgeries, and other related neurological
disorders that may improve patient outcomes and reduce procedural
costs. The Company may also pursue applications for other areas
such as depression, mood disorders, pain, incontinence, high blood
pressure, and artificial intelligence. For more information,
visit nmtc1.com.
Contact:
800-631-4030 ir@nmtc1.com
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Sep 2024 to Oct 2024
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Oct 2023 to Oct 2024